tiprankstipranks
Advertisement

DIVI - ETF AI Analysis

Compare

Top Page

DIVI

Franklin LibertyQ International Equity Hedged ETF (DIVI)

Rating:66Neutral
Price Target:
DIVI, the Franklin LibertyQ International Equity Hedged ETF, earns a solid overall rating thanks to several high-quality global leaders like HSBC, AstraZeneca, Novartis, and Toyota, which show strong financial health, positive earnings commentary, and generally supportive technical and valuation trends. Defensive giants such as Nestlé, Roche, and Siemens further support the fund with stable cash flows and reasonable valuations, though occasional overvaluation signals and short-term bearish or mixed technical trends in names like Roche and BHP slightly weigh on the rating. The main risk factor is that many top holdings are large, mature companies in similar developed markets, so the fund’s performance is closely tied to broader conditions in global blue-chip equities rather than high-growth niches.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Low Expense Ratio
The fund charges a relatively low management fee, which helps investors keep more of their returns over time.
Broad International Diversification
Holdings spread across many countries and sectors help reduce the impact if any single market or industry struggles.
Negative Factors
Heavy Japan Exposure
A large portion of the portfolio is invested in Japan, which increases the fund’s sensitivity to economic and market conditions there.
Mixed Performance Among Top Holdings
While some leading positions have performed strongly, others have been weak, which can create uneven contributions to returns.
Concentration in Financials
A sizable allocation to financial stocks means the ETF could be more affected by changes in interest rates and banking sector stress.

DIVI vs. SPDR S&P 500 ETF (SPY)

DIVI Summary

DIVI is an ETF that follows the Morningstar Developed Markets ex-North America Dividend Enhanced Select Index, focusing on international companies that pay higher dividends, while also hedging currency swings. It holds well-known names like ASML, Nestlé, Toyota, and HSBC, giving investors broad exposure to markets such as Japan, the UK, and Europe in one fund. Someone might invest in DIVI to seek regular income from dividends and diversify beyond U.S. stocks without worrying as much about foreign exchange moves. A key risk is that international stock prices can still rise and fall significantly with global markets.
How much will it cost me?The Franklin LibertyQ International Equity Hedged ETF (DIVI) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it is passively managed, focusing on tracking an index rather than active stock selection.
What would affect this ETF?The Franklin LibertyQ International Equity Hedged ETF (DIVI) could benefit from stable or growing dividend payouts in developed markets outside North America, particularly in sectors like financials and technology, which are its largest exposures. However, economic slowdowns or regulatory changes in these regions, as well as sector-specific challenges like reduced demand in industrials or healthcare, could negatively impact performance. Additionally, while currency hedging reduces volatility, unexpected shifts in global trade policies or geopolitical tensions might still affect the ETF's returns.

DIVI Top 10 Holdings

DIVI’s story is all about steady income from overseas blue chips, with a clear tilt toward Europe and other developed markets outside North America. ASML is the star of the show, rising strongly and giving the fund a tech-powered boost, while financial heavyweights like HSBC and BNP Paribas are also climbing and helping to pull returns higher. On the defensive side, health care names such as AstraZeneca and Novartis are holding up well, but Roche looks sluggish, and Toyota plus Nestlé have been losing steam, quietly tugging on performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.71%$66.14M€498.49B113.07%
76
Outperform
HSBC Holdings1.46%$35.69M£230.84B59.32%
80
Outperform
Nestlé SA1.35%$32.90MCHF198.82B-4.90%
71
Outperform
Roche Holding AG1.32%$32.11M$330.18B27.90%
73
Outperform
AstraZeneca1.30%$31.60M$286.22B29.15%
80
Outperform
Novartis AG1.12%$27.28MCHF211.11B25.94%
80
Outperform
Siemens1.11%$27.16M€204.52B27.59%
74
Outperform
Toyota Motor1.08%$26.33M¥39.10T10.86%
80
Outperform
Intesa Sanpaolo SpA1.05%$25.51M€103.44B26.73%
76
Outperform
BHP Group Ltd1.02%$24.97MAU$286.50B75.00%
68
Neutral

DIVI Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
40.98
Positive
100DMA
40.68
Positive
200DMA
38.62
Positive
Market Momentum
MACD
0.38
Negative
RSI
63.11
Neutral
STOCH
70.50
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 42.07, equal to the 50-day MA of 40.98, and equal to the 200-day MA of 38.62, indicating a bullish trend. The MACD of 0.38 indicates Negative momentum. The RSI at 63.11 is Neutral, neither overbought nor oversold. The STOCH value of 70.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVI.

DIVI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.45B0.09%
66
Neutral
$8.36B0.50%
59
Neutral
$2.28B0.09%
68
Neutral
$1.40B0.55%
59
Neutral
$686.70M0.58%
62
Neutral
$48.13M0.55%
56
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DIVI
Franklin LibertyQ International Equity Hedged ETF
43.21
10.57
32.38%
IDV
iShares International Select Dividend ETF
HDEF
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
FGD
First Trust Dow Jones Global Select Dividend Index Fund
DTH
WisdomTree International High Dividend Fund
EFAS
Global X MSCI SuperDividend EAFE ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement